Innovating Works

Beiter GmbH&CoKG

Desconocido
N2B-patch: Nose to Brain Delivery of Antibodies via the Olfactory Region for the Treatment of Multiple Sclerosi... BEITER GMBH GO KG participó en un H2020: H2020-NMBP-2016-2017 The overall aim of N2B-patch is the development of a new innovative N2B drug delivery technology based on the synthesis of a biomaterial-bas...
2016-11-09 - 2021-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.